Italy Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Italy Diabetes Care Devices Market is Segmented Into Management Devices (insulin Pumps (insulin Pump Device, Insulin Pump Reservoirs, and Infusion Sets), Insulin Syringes, Insulin Cartridges in Reusable Pens, Disposable Insulin Pens, and Jet Injectors) and Monitoring Devices (self-Monitoring Blood Glucose (glucometer Devices, Blood Glucose Test Strips, and Lancets) and Continuous Glucose Monitoring (sensors and Durables)). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Italy Diabetes Care Devices Market Size

Single User License


Team License


Corporate License


Book before:
View Global Report
Italy Diabetes Care Devices Market Summary
Study Period 2019- 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 1.03 Billion
Market Size (2029) USD 1.45 Billion
CAGR (2024 - 2029) 6.70 %

Major Players

Italy Diabetes Care Devices Market

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Italy Diabetes Care Devices Market Analysis

The Italy Diabetes Care Devices Market size is estimated at USD 1.03 billion in 2024, and is expected to reach USD 1.45 billion by 2029, growing at a CAGR of 6.70% during the forecast period (2024-2029).

Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was the first country in Europe affected by COVID-19. Italy is among the countries with the highest excess mortality. Most people who have died of COVID-19 were affected by the co-occurrence of two or more chronic conditions in the same individual. Several studies have confirmed that chronic diseases like diabetes are associated with adverse outcomes in COVID-19 patients.

The COVID-19 pandemic has significantly impacted Italy's diabetes care devices. The pandemic highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care, through virtual consultations between healthcare providers and people with diabetes, and the use of diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the diabetes care device market's growth.

About 9.9% of the Italian population has diabetes as of 2021. The rate of newly diagnosed Type 1 and Type 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. In May 2021, the World Health Assembly agreed on a Resolution on strengthening the prevention and control of diabetes. It recommends action in areas including increasing access to insulin; promoting convergence and harmonization of regulatory requirements for insulin and other medicines and health products for the treatment of diabetes; and assessing the feasibility and potential value of establishing a web-based tool to share information relevant to the transparency of markets for diabetes medicines and health products.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Italy Diabetes Care Devices Market Trends

The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period

The continuous glucose monitoring segment is expected to record a CAGR of more than 10.8% over the forecast period.

Continuous Glucose Monitoring Devices are automated glucose monitoring systems that consist of a small device that can be worn on the body and held on by an adhesive patch. The sensor part of the device includes a cannula inserted into the top layer of skin and uses interstitial fluid samples to check glucose levels. Sensors are connected to a transmitter that can send data wirelessly to a dedicated mobile receiving device or smartphone. CGM makes it significantly easier to manage blood glucose levels by decreasing interruptions and allowing for better sleep. It also improves the mental health of patients or caregivers by reducing the overall mental load of managing diabetes, thereby enhancing the market prospects in the coming years.

The current CGM devices show a detailed representation of blood glucose patterns and tendencies compared to a routine check of glucose levels at set intervals. These technologies overcome many limitations of self-monitoring blood glucose by fingerprick and allow one to go beyond HbA1c to check glucose control in diabetes. Furthermore, the technological advancements in continuous glucose monitoring sensors opened new scenarios to assess, off-line, the effectiveness of individual patient therapeutic plans and stimulated the development of innovative online applications. It includes hypoglycemia or hyperglycemia alert systems and artificial pancreas closed-loop control algorithms.

The Italian National Healthcare Service (NHS) is ensuring universal coverage for all citizens. People living with diabetes can access all the medicines, devices, and medical services they need with no out-of-pocket expenditure. Overall, Italy includes a well-developed system of diabetes care, with numerous diabetes centers throughout the country and treatment free at the point of delivery.

The factors above are likely to drive segment growth during the forecast period.

 Italy Diabetes Care Devices Market, Diabetes population in million, 2017-2022

Insulin disposable pens occupied the highest share in the management devices segment in the current year

Insulin Disposable pens occupied the highest market share of more than 43% in the management devices segment in the current year.

A disposable insulin pen contains a prefilled amount of insulin. When the pen is empty, it is thrown away. Insulin pens are much smaller, more portable than syringes, and contain the medicine preloaded into the delivery mechanism. The needles are easy to use and can be disposed of by twisting or snapping. The pens are usually color-coded, making it easier to know which type and how much insulin will be received from them. The disposable insulin pens are considered more consumer-friendly, as they are smaller and less noticeable than the classic vial-and-syringe. These devices are also more portable for consumers. Some pens are smart insulin pens that easily connect to an app on the phone to monitor blood sugar levels and remind when to take the next insulin dose.

Italian law regulates the clinical care of people with diabetes and creates a framework involving medical organizations, prevention programs, personnel training, and legal protection. The National Health Program is structured in essential levels of assistance that can be defined differently in the various regions. The National Health Program is structured in LEAs (essential levels of assistance). LEAs define all the medical assistance modalities offered by the INHS to citizens, with or without partial contributions, based on a patient's income. The Insulin pens are free for all diabetic patients in Italy, but they must still adhere to a nominal set of medical assistance guidelines that remain free of charge.

Technological development is gaining momentum in the insulin devices market. Several technological innovations were developed over many years, creating new types of devices that are much less cumbersome and more comfortable for patients than traditional ones. Such advantages helped increase these products' adoption in the Italian market.

Italy Diabetes Care Devices Market, Volume CAGR (%), by Management devices, 2023-2028

Italy Diabetes Care Devices Industry Overview

The Italian diabetes care devices market is semi-consolidated, driven by manufacturers like Roche, Abbott, Novo Nordisk, Dexcom, Medtronic, etc., and other generic players.

Italy Diabetes Care Devices Market Leaders

  1. Abbott Diabetes Care

  2. Roche Diabetes Care

  3. LifeScan Inc.

  4. Medtronic PLC

  5. Dexcom Inc.

*Disclaimer: Major Players sorted in no particular order

Italy Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Italy Diabetes Care Devices Market News

  • June 2022: Cequr, the leader in wearable diabetes technology, released their newest and most innovative insulin delivery device yet, the Insulin Pen 2.0TM. The pen is small enough to be always worn on the user's body. It also features a built-in blood glucose meter so users can track their blood sugar throughout the day.
  • January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its apps. The hand-held Cobas pulse includes an automated glucose test strip reader, a camera, and a touchscreen for logging other diagnostic results. It's designed for patients of all ages, including neonates and people in intensive care.

Italy Diabetes Care Devices Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 Management Devices

      1. 5.1.1 Insulin Pump

        1. Insulin Pump Device

        2. Insulin Pump Reservoir

        3. Infusion Set

      2. 5.1.2 Insulin Syringes

      3. 5.1.3 Cartridges in Reusable Pens

      4. 5.1.4 Insulin Disposable Pens

      5. 5.1.5 Jet Injectors

    2. 5.2 Monitoring Devices

      1. 5.2.1 Self-monitoring Blood Glucose

        1. Glucometer Devices

        2. Blood Glucose Test Strips

        3. Lancets

      2. 5.2.2 Continuous Glucose Monitoring

        1. Sensors

        2. Durables


    1. 6.1 Type-1 Diabetes Population

    2. 6.2 Type-2 Diabetes Population


    1. 7.1 Company Profiles

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche Diabetes Care

      3. 7.1.3 LifeScan Inc.

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray Inc.

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Novo Nordisk A/S

      9. 7.1.9 Eli Lilly

      10. 7.1.10 Sanofi

      11. 7.1.11 Insulet Corporation

      12. 7.1.12 Rossmax International Ltd.

    2. *List Not Exhaustive
    3. 7.2 Company Share Analysis

      1. 7.2.1 Self-monitoring Blood Glucose Devices

        1. Abbott Diabetes Care

        2. LifeScan

        3. Others

      2. 7.2.2 Continuous Glucose Monitoring Devices

        1. Dexcom Inc.

        2. Medtronic PLC

        3. Others

      3. 7.2.3 Insulin Devices

        1. Insulet Corporation

        2. Novo Nordisk A/S

        3. Others


**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Italy Diabetes Care Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The Italy diabetes care devices market is segmented into management devices (insulin pumps (insulin pump device, insulin pump reservoir, and infusion set), insulin syringes, insulin cartridges in reusable pens, disposable insulin pens, and jet injectors) and monitoring devices (self-monitoring blood glucose (glucometer devices, blood glucose test strips, and lancets) and continuous glucose monitoring (sensors and durables)). The report offers the value (in USD) and volume (in units) for the above segments.

Management Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable Pens
Insulin Disposable Pens
Jet Injectors
Monitoring Devices
Self-monitoring Blood Glucose
Glucometer Devices
Blood Glucose Test Strips
Continuous Glucose Monitoring
Need A Different Region Or Segment?
Customize Now

Italy Diabetes Care Devices Market Research FAQs

The Italy Diabetes Care Devices Market size is expected to reach USD 1.03 billion in 2024 and grow at a CAGR of 6.70% to reach USD 1.45 billion by 2029.

In 2024, the Italy Diabetes Care Devices Market size is expected to reach USD 1.03 billion.

Abbott Diabetes Care, Roche Diabetes Care, LifeScan Inc., Medtronic PLC and Dexcom Inc. are the major companies operating in the Italy Diabetes Care Devices Market.

In 2023, the Italy Diabetes Care Devices Market size was estimated at USD 0.96 billion. The report covers the Italy Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Italy Diabetes Care Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Diabetes Care Devices in Italy Industry Report

Statistics for the 2024 Diabetes Care Devices in Italy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Diabetes Care Devices in Italy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Italy Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)